CD274 and cancer: We has demonstrated that PPIs promote PD‐L1 translocation in an array of cancer cells in vitro, and the concurrent administration of PD‐L1 inhibitors and PPIs in vivo appears to synergistically impede the progression of lung and colon cancers.